[ad_1]
AstraZeneca suspended clinical trials of its COVID-19 vaccine due to an adverse reaction in a volunteer, Reuters said on Tuesday.
British pharmaceutical AstraZeneca, which is developing a possible vaccine against the new coronavirus in conjunction with the University of Oxford, was already in an advanced phase of large-scale clinical trials.
According to a company spokesperson, quoted by the health news website Statistics News, it’s about “a normal procedure” for “allow security data to be reviewed”.
It is a routine procedure that is opened whenever there is a potentially unexplained illness during a trial, so that it can be investigated, ensuring the integrity of the trials “, clarified the pharmacist.
A AstraZeneca He also admitted that the adverse reaction in the volunteer, which was detected in the UK, may not be caused by the vaccine.
In large-scale testing, diseases occur by chance, but they must be independently reviewed in order to carefully monitor them. We are working to speed up the review of a single event to minimize any potential impact on the testing program. We are committed to the safety of our participants and the highest standards of conduct in our tests “, justified.
On August 27, the European Commission made official the purchase of 300 million doses this vaccine.
In an article published in the magazine The lancet, scientists at the University of Oxford said preliminary results of tests with the covid-19 vaccine showed that triggered an immune response in hundreds of people.
